We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Japanese pharmaceuticals major Sankyo and US drug company Metabasis Therapeutics
have announced the start of Phase IIb clinical trials of a compound to treat
Type 2 diabetes, known as CS-917.
Taiwanese biotechnology company TaiGen has announced
a new strategic alliance with the pharmaceuticals unit of US consumer goods
major Procter & Gamble.
Although much reform is still required, the United Arab Emirates has continued
to bring domestic pharmaceutical legislation into line with international norms.
According to international press reports, an anonymous statement
posted on the website of South Africa's ruling party, the ANC, has accused German
drug major Boehringer Ingelheim of "concealing deadly side effects"
on its HIV/AIDS treatment Viramune.
Brazilian drug regulator Anvisa has indefinitely suspended
production at Sao Paulo-based producer Clímax SA, due to the company's
alleged failure to meet manufacturing quality requirements.
According to official sources, Czech drug spending increased slightly in January
through September 2004, to some CZK40.7bn (US$1.77bn), representing a rise of
4.5%.